Ignite Creation Date:
2024-05-06 @ 12:19 AM
Last Modification Date:
2024-10-26 @ 10:48 AM
Study NCT ID:
NCT01544920
Status:
COMPLETED
Last Update Posted:
2018-09-11
First Post:
2012-02-28
Brief Title:
Safety and Efficacy of BoceprevirPeginterferon Alfa-2aRibavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus HCV Genotype 1 Participants P07755
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Organization Data
Organization:
Merck Sharp Dohme LLC
Class:
INDUSTRY
Study ID:
P07755
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merck Sharp Dohme LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None